TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

Daniel Brennan

Managing Director, Research, Health Care - Life Science & Diagnostic Tools

Headshot photo of Daniel Brennan

At TD Cowen, Dan is responsible for providing research coverage on a diverse group of companies across the Life Science & Diagnostics Tools’ industry. This includes identifying key investment debates, building financial models, generating research reports, including ‘Ahead of the Curve’ deep dive analysis, making stock recommendations and engaging with clients and TD Cowen representatives.

Daniel Brennan is a senior analyst covering Life Science & Diagnostic Tools. Prior to joining TD Cowen, Dan was a Managing Director and senior Life Science & Diagnostic Tools analyst at UBS. Prior to UBS, he was a senior health care analyst at Columbus Circle Investors. Dan also spent 19 years at Morgan Stanley, where he served, amongst other roles, as the health care sector equity sales specialist and later as the senior Life Science & Diagnostic Tools analyst.

Mr. Brennan holds a BA in economics from Georgetown University, and an MBA from Harvard University. He is also a CFA® charterholder.


Get In Touch

Start a conversation with Daniel Brennan


    Explore related thought leadership, reports, coverage and insights for Daniel Brennan.

    Biochemist in lab wearing lab coat. blue gloves, and goggles is looking at a blue liquid solution in a glass flask.
    Ahead of the Curve®

    Liquid Biopsy: 10 Years In & We’ve Only Just Begun

    A young female researcher in a lab coat is conducting research on a computer.
    Ahead of the Curve®

    AI In Drug Development: From Hype To The Clinic & Beyond

    A son, older in age and dressed in a red and blue collored shirt holds the hand of his ailing elderly mother with both of his own hands.
    Ahead of the Curve®

    Alzheimer’s Coming of Age Moment